(West Palm Beach, Florida) July 30, 2019

Credit: Digestive Surgery Clinic

Academy Medical is pleased to announce their new partnership with BONESUPPORT Inc. (the wholly owned subsidiary of BONESUPPORT AB), a public company based in Lund, Sweden (Nasdaq Stockholm: BONEX). The Scandinavian orthobiologics company will be marketing their flagship product, CERAMENT®|BONE VOID FILLER, into the Veterans Administration (VA) and Department of Defense (DOD) Hospitals through Academy Medical.  CERAMENT® is an industry leading synthetic bone graft substitute that is utilized by orthopedic surgeons to help heal bone voids and fractures caused by trauma, infection, or disease in various applications.

“We believe our partnership with Academy Medical will greatly impact the rapid growth of our U.S. business by leveraging the immediate opportunity for CERAMENT® at the numerous VA and DOD hospitals.  More importantly, access to the VA will pave the way for CERAMENT G, the only CE-marked gentamicin-eluting ceramic bone graft substitute on the market.  CERAMENT G is currently being evaluated in the U.S. as part of a FDA PMA (Premarket Approval) study and Regulatory approval is expected in the U.S. in 2021.  The VA and DOD hospitals are ideally suited to benefit from the drug-eluting capabilities of our platform technology and we are proud to have the opportunity to serve them through Academy Medical,” says BONESUPPORT CEO Emil Billbäck.

Credit: Physician’s Weekly

Academy Medical’s goal is to provide the most advanced medical and surgical products to help the federal government ensure the best healthcare possible for veterans, active military members, and their families.  Academy Medical works with their extensive network of vendors to provide access to government contracts and open sales channels, thus ensuring the most advanced technology is readily available to government clinicians and medical facilities across the country.

Credit: Association of American Physicians and Surgeons

“The government procurement process is, in many ways, a challenge for all companies, small or large,” Academy Medical President, Dan Shaw, says. “Many businesses often don’t have the expertise, resources, or even the patience to deal with the bureaucracy and systemic issues embedded in the government contracting process.  Academy Medical is well positioned to help these companies navigate the contracting process– dramatically shortening wait times which results in quicker access and revenue turns with emerging technologies.”

For more information about Academy Medical, their services, and their vendors, call (888) 860-0561, email info@academymedical.net.

380 Columbia Dr STE 100, West Palm Beach, FL 33409


BONESUPPORT Inc. is located in Boston and is a wholly owned subsidiary of BONESUPPORT AB. BONESUPPORT develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver and a Premarket approval filing with the FDA (USA) for its gentamicin eluting product is planned in 2020. Please visit www.bonesupport.com for more information. 

BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.